Why QuantumScape Stock Is Sinking Today
QuantumScape ( NYSE: QS ) stock is slumping in Wednesday's trading. The solid-state battery company's share price was down 4.2% as of 3:15 p.m. ET and had been down as much as 5.4% earlier in the day's trading.While there isn't any fresh business-specific news for QuantumScape today, the ...
Elliott Investment Management Buys Wolfspeed Stock, Bets Against Nvidia In Q4 - Wolfspeed ( NYSE:WOLF )
Elliott buys shares of Wolfspeed, adds to existing positions in MicroStrategy and CorMedix in the fourth quarter. Elliott closes positions in Catalent, Cardinal Health, Unity Software and BILL Holdings in the quarter.
UnitedHealthcare Offers Voluntary Buyouts, Possible Layoffs If Targets Not Met: CNBC - UnitedHealth Group ( NYSE:UNH )
UnitedHealthcare's Q4 revenue rose to $74.1 billion from $70.8 billion a year ago. Domestic commercial benefits enrollment grew by 2.4 million in 2024. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, and real-time market insights.
Aptos Price Surges as Traders Fuel 'Community Takeover' With Memes
Aptos just got a vibe shift in an unconventional "community takeover" led by a degen trader called BuzzlamicJihad, causing APT to spike.
Edison International Investors: Please contact the Portnoy Law Firm to recover your losses. April 21, 2025 Deadline to file Lead Plaintiff Motion - Edison Intl ( NYSE:EIX )
Investors can contact the law firm at no cost to learn more about recovering their losses
Fed Minutes Reveal Officials See 'High Degree Of Uncertainty' Requiring 'A Careful Approach' On Rate Cuts - SPDR S&P 500 ( ARCA:SPY )
Minutes from the January FOMC reveal participants stressed the need for additional evidence that inflation was cooling. Officials note a "high degree of uncertainty" that requires the Fed to "take a careful approach" in considering any further rate cuts.
BioAge Labs ( BIOA ) Abandons Obesity Drug Amid Shareholder Lawsuit - Hagens Berman - Bioage Labs ( NASDAQ:BIOA )
SAN FRANCISCO, Feb. 19, 2025 ( GLOBE NEWSWIRE ) -- BioAge Labs, Inc. BIOA is abandoning development of its lead obesity candidate, azelaprag, just weeks after halting a Phase 2 trial. The biotech firm is pivoting to a preclinical neuroinflammation program, according to a recent company disclosure.
Regeneron Pharmaceuticals ( REGN ) Faces Mounting Pressure on Sales, Legal Fronts - Hagens Berman - Regeneron Pharmaceuticals ( NASDAQ:REGN )
SAN FRANCISCO, Feb. 19, 2025 ( GLOBE NEWSWIRE ) -- Regeneron Pharmaceuticals Inc. REGN is facing headwinds on multiple fronts, including disappointing sales figures, ongoing legal challenges, and analyst downgrades.
Vireo Growth Inc. to Release Fourth Quarter and Full Year 2024 Results on March 4, 2025 - Vireo Growth ( OTC:VREOF )
MINNEAPOLIS, Feb. 19, 2025 ( GLOBE NEWSWIRE ) -- Vireo Growth Inc. ( "Vireo" or the "Company" ) VREOVREOF, today announced that it will release its financial results for its fourth quarter and fiscal year ended December 31, 2024 on Tuesday, March 4, 2025 before the market opens.
Rectitude Delivers First Batch of AIMS Products to Singapore Customers, Expanding Green Energy Offerings in Southeast Asia
SINGAPORE, Feb. 19, 2025 ( GLOBE NEWSWIRE ) -- Rectitude Holdings Ltd. ( Nasdaq: RECT. the "Company" or "Rectitude" ) , a Singapore-based provider of safety equipment and related industrial products, today announced the successful delivery of its first batch of All-in-One Intelligence Micro-grid ...
